Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2014
10/02/2014US20140294859 Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration
10/02/2014US20140294853 Antagonistic dr3 ligands
10/02/2014US20140294852 Monoclonal antibodies to programmed death 1 (pd-1)
10/02/2014US20140294851 Cleavable drug conjugates, compositions thereof and methods of use
10/02/2014US20140294845 Anti-pleiotrophin antibodies and methods of use thereof
10/02/2014US20140294821 Factor viii chimeric and hybrid polypeptides, and methods of use thereof
10/02/2014US20140294797 Non-cytotoxic protein conjugates
10/02/2014US20140294787 Extensional viscosity to promote safe swallowing of food boluses
10/02/2014US20140294782 Reprogramming of Cellular Adhesion
10/02/2014US20140294762 Glycopegylation methods and proteins/peptides produced by the methods
10/02/2014US20140294758 Light chain immunoglobulin fusion proteins and methods of use thereof
10/02/2014US20140294757 Stabilisation of polypeptides
10/02/2014US20140294756 Long-Term Storage of Non-Glycosylated Recombinant Human G-CSF
10/02/2014US20140294755 Materials and Methods Relating to Stem Cell Mobilization by Multi-Pegylated Granulocyte Colony Stimulating Factor
10/02/2014US20140294752 Method for nucleic acid delivery using hyaluronic acid
10/02/2014US20140294750 Aqueous pharmaceutical compositions containing borate-polyol complexes
10/02/2014US20140294733 Multifunctional small molecules
10/02/2014US20140294727 Peptides for assisting delivery across the blood brain barrier
10/02/2014US20140294724 Compositions and methods for treatment of proteinopathies
10/01/2014EP2784093A1 Polyethylene glycol-modified integrin blocker hm-3 and use thereof
10/01/2014EP2784081A1 Development of novel macromolecule transduction domain with improved cell permeability and method for using same
10/01/2014EP2783704A1 Pharmaceutical composition useful for adhesion prevention or hemostasis
10/01/2014EP2783702A1 Water insoluble gel composition and method for preparing same
10/01/2014EP2783679A1 Drug carrier with chelating composite micell and use thereof
10/01/2014EP2782926A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery
10/01/2014EP2782555A2 Platelet lysate gel
09/2014
09/30/2014US8846941 Functionalized polymers
09/30/2014US8846904 Water-soluble porphyrin and process for production thereof
09/30/2014US8846894 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
09/30/2014US8846893 Non-ionically bound constructs, and compositions and kits comprising domains
09/30/2014US8846875 Preparation and/or purification of oligonucleotide conjugates
09/30/2014US8846874 IgG Fc fragment for a drug carrier and method for the preparation thereof
09/30/2014US8846873 Antibodies directed to GPNMB and uses thereof
09/30/2014US8846861 Peptide clearing agents
09/30/2014US8846853 Polycondensation of lactic acid for medical biodegradable polylactic acid catalyzed by creatinine
09/30/2014US8846843 Silicone modified fatty acids, method of preparation and usage thereof
09/30/2014US8846771 Compositions and methods of delivery of pharmacological agents
09/30/2014US8846770 Controlled release aural pressure modulator compositions and methods for the treatment of OTIC disorders
09/30/2014US8846769 Composition made of polyalkoxylated derivatives of trimethylolpropane and fatty alcohols, method for preparing said composition, and use thereof as a reverser in self-reversible reverse latexes
09/30/2014US8846744 Pharmaceutical compositions of co-crystals of tramadol and coxibs
09/30/2014US8846740 Biotherapeutics for the treatment of infectious diseases
09/30/2014US8846725 Highly penetrating compositions and methods for treating pathogen-induced disordered tissues
09/30/2014US8846680 Pharmaceutical composition comprising pimobendan
09/30/2014US8846679 Pharmaceutical composition comprising pimobendan
09/30/2014US8846664 Pyrazinopyrazines and derivatives as kinase inhibitors
09/30/2014US8846651 Lipid composition having excellent shape retention property and product
09/30/2014US8846650 Method of treating middle ear infections
09/30/2014US8846646 Topical treatment of skin infection
09/30/2014US8846644 Phosphate-containing nanoparticle delivery vehicle
09/30/2014US8846633 Method for inhibiting cancer stem cell like properties and chemoradioresistant properties of cancer or tumor cells with microRNA145
09/30/2014US8846623 Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
09/30/2014US8846620 Resorption enhancers as additives to improve the oral formulation of non-anticoagulant sulfated polysaccharides
09/30/2014US8846618 Stable formulation of modified GLP-1
09/30/2014US8846616 Alpha-melanocyte stimulating hormone as topical anti-inflammatory agent for the treatment of allergic contact dermatitis and eczema
09/30/2014US8846605 Formulations and methods of use for alpha connexin C-terminal (ACT) peptides
09/30/2014US8846604 Lipid compositions with high DHA content
09/30/2014US8846602 Process for producing an injectable medicament preparation
09/30/2014US8846110 Polymeric systems for the delivery of anticancer drugs
09/30/2014US8846106 Enhanced transport using membrane disruptive agents
09/30/2014US8846102 Non-viral compositions and methods for transfecting gut cells in vivo
09/30/2014US8846098 Artificial cell constructs for cellular manipulation
09/30/2014US8846094 Peripherally administered viscous formulations
09/30/2014US8846092 Gum resin as a carrier for topical application of pharmacologically active agents
09/30/2014US8846091 Matrix for sustained, invariant and independent release of active compounds
09/30/2014US8846090 Matrix for sustained, invariant and independent release of active compounds
09/30/2014US8846089 Sugar-coated preparation and production method for the same
09/30/2014US8846086 Tamper resistant dosage forms
09/30/2014US8846083 Method for the diffusion of molecules which are insoluble in an aqueous medium and composition using said method
09/30/2014US8846077 High throughput fabrication of nanoparticles
09/30/2014US8846074 Sublingual films
09/30/2014US8846072 Controlled delivery system
09/30/2014US8846070 Biologically degradable compositions for medical applications
09/30/2014US8846068 Methods and compositions for treating post-operative pain comprising a local anesthetic
09/30/2014US8846066 Methods and related compositions for reduction of fat and skin tightening
09/30/2014US8846062 Reaction product of a polar modified polymer and an alkoxysilane and a composition containing the reaction product
09/30/2014US8846044 Stabilizing alkylglycoside compositions and methods thereof
09/30/2014US8846035 Methods for preparing polymer microparticles
09/30/2014US8846026 Composition comprising immunogenic microparticles
09/30/2014US8846021 Acryloyloxyethylphosphorylcholine containing polymer conjugates and their preparation
09/30/2014US8846020 Scaffolds formed from polymer-protein conjugates, methods of generating same and uses thereof
09/30/2014US8846009 Antimicrobial agents and methods of use
09/30/2014US8846008 Antimicrobial agents and methods of use
09/30/2014US8846002 Anti-CD74 immunoconjugates and methods of use
09/30/2014CA2758820C Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
09/30/2014CA2590935C Fc.gamma.riib-specific antibodies and methods of use thereof
09/30/2014CA2510373C Compounds for oral dosage of active substances requiring a taste masking
09/30/2014CA2356706C Novel exendin agonist formulations and methods of administration thereof
09/30/2014CA2252439C Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens
09/25/2014WO2014153394A1 Cellular delivery of dna intercalating agents
09/25/2014WO2014153192A1 Pharmaceutical formulations of chelating agents as a metal removal treatment system
09/25/2014WO2014153164A1 Targeting agent antibody conjugates and uses thereof
09/25/2014WO2014153038A1 Biocompatible hydrogel polymer matrix for delivery of cells
09/25/2014WO2014152941A1 Conjugated gold nanoparticles
09/25/2014WO2014152823A1 Local drug delivery
09/25/2014WO2014152796A2 Biocompatible and bioabsorbable derivatized chitosan compositions
09/25/2014WO2014152790A1 Chelated drug delivery systems
09/25/2014WO2014152774A1 Methods and compositions for delivering mrna coded antibodies
09/25/2014WO2014152661A1 Ocular formulations for drug-delivery to the posterior segment of the eye
09/25/2014WO2014152504A1 Method of treating vitamin b12 deficiency
09/25/2014WO2014152451A2 Compositions and methods for controlled localized delivery of bone forming therapeutic agents
1 ... 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 ... 1712